Anti-encystment and amoebicidal activity of Lonicera japonica Thunb. and its major constituent chlorogenic acid in vitro

Asian Pacific Journal of Tropical Medicine

Volumn 9, Issue 9, 2016, Pages 866-871

  Mahboob, Tooba ^a   Azlan, Abdul Majid ^a   Tan, Tian Chye ^a   Samudi, Chandramathi ^a   Sekaran, Shamala Devi ^a   Nissapatorn, Veeranoot ^a   Wiart, Christophe ^b  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b UNIVERSITY OF NOTTINGHAM MALAYSIA CAMPUS   (Malaysia)

Author keywords

Acanthamoeba spp.; Amoebicidal; Chlorogenic acid; Encystment; Lonicera japonica Thunb.

Indexed keywords

ACETIC ACID ETHYL ESTER; BUTANOL; CHLORHEXIDINE; CHLOROGENIC ACID; HYDROGEN PEROXIDE; LONICERA JAPONICA EXTRACT; PHENOL DERIVATIVE;

ACANTHAMOEBA; ACANTHAMOEBA TRIANGULARIS; ACANTHAMOEBICIDAL ACTIVITY; AMOEBICIDAL ACTIVITY; ANTIENCYSTMENT ACTIVITY; AQUEOUS SOLUTION; ARTICLE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; CYST TROPHOZOITE RATIO; DOSE TIME EFFECT RELATION; DRUG ACTIVITY; DRUG CONCENTRATION; DRUG EXPOSURE; DRUG ISOLATION; DRUG STRUCTURE; FLOWER; FLOWER BUD; IN VITRO STUDY; MICROBIOLOGICAL PHENOMENA AND FUNCTIONS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TROPHOZOITE VIABILITY;

EID: 84995545967     PISSN: 19957645     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apjtm.2016.07.008     Document Type: Article

References (33)

1. [1] Visvesvara, G.S., Free-living pathogenic amoebae. Lennette, E.H., Hausler, W.J., Truant, J.P., (eds.) Manual of clinical microbiology, 3rd ed., 1980, American Society for Microbiology, Washington, DC, 704-708.
2. [2] Marciano-Cabral, F., Cabral, G., Acanthamoeba spp. as agents of disease in humans. Clin Microbiol Rev 16:2 (2003), 273-307.
3. [3] Khan, N.A., Acanthamoeba and the blood-brain barrier: the breakthrough. Med Microbiol 57 (2008), 1051-1057.
4. [4] Khan, N.A., Pathogenesis of Acanthamoeba infections. Microb Pathog 34 (2003), 277-285.
5. [5] Neff, R.J., Ray, S.A., Benton, W.F., Wilborn, M., Prescott, D.M., (eds.) Methods in cell physiology, 1964, Academic Press, New York, 55-83.
6. [6] Loyd, D., Encystment in Acanthamoeba castellanii: a review. Exp Parasitol 145 (2014), S20-S27.
7. [7] Pussard, M., Pons, R., Morphology of cystic wall and taxonomy of genus Acanthamoeba (Protozoa, Amoebida). Protistologica 13:4 (1977), 557-598.
8. [8] Xuan, Y.H., Chung, B.S., Hong, Y.C., Kong, H.H., Hahn, T.W., Chung, D.I., Keratitis by Acanthamoeba triangularis: report of cases and characterization of isolates. Korean J Parasitol 46:3 (2008), 157-164.
9. [9] Malatyali, E., Tepe, B., Degerli, S., Berk, S., In vitro amoebicidal activities of Satureja cuneifolia and Melissa officinalis on Acanthamoeba castellanii cysts and trophozoites. Parasitol Res 110 (2012), 2175-2180.
10. [10] Ródio, C., da Rocha Vianna, D., Kowalski, K.P., Panatieri, L.F., von Poser, G., Rott, M.B., In vitro evaluation of the amebicidal activity of Pterocaulon polystachyum (Asteraceae) against trophozoites of Acanthamoeba castellanii. Parasitol Res 104 (2008), 191-194.
11. [11] Dorman, H.J., Bachmayer, O., Kosar, M., Hiltunen, R., Antioxidant properties of aqueous extracts from selected Lamiaceae species grown in Turkey. J Agric Food Chem 52:4 (2004), 762-770.
12. [12] Pereira, R.P., Fachinetto, R., de Souza Prestes, A., Puntel, R.L., Santos da Silva, G.N., Heinzmann, B.M., et al. Antioxidant effects of different extracts from Melissa officinalis, Matricaria recutita and Cymbopogon citratus. Neurochem Res 34 (2009), 973-983.
13. [13] Shang, X., Pan, H., Li, M., Miao, X., Ding, H., Lonicera japonica Thunb.: ethnopharmacology, phytochemistry and pharmacology of an important traditional Chinese medicine. J Ethnopharmacol 138 (2012), 1-21.
14. [14] Schroeder, J.M., Booton, G.C., Hay, J., Niszl, I.A., Seal, D.V., Markus, M.B., et al. Use of subgenic 18S ribosomal DNA PCR and sequencing for genus and genotyping identification of Acanthamoeba from humans with keratitis and from sewage sludge. J Clin Microbiol, 9, 2001, 1930.
15. [15] Garcia, L.S., Brucker, D.A., Diagnostic medical parasitology. 2nd ed., 1993, ASM Press, Washington, 601.
16. [16] Khan, N.A., Acanthamoeba: biology and pathogenesis. 2009, Caister Academic Press, Norfolk UK, 85.
17. [17] Auran, J.D., Starr, M.B., Jakobiec, F.A., Acanthamoeba keratitis. A review of the literature. Cornea 6 (1987), 2-26.
18. [18] Nakisah, M.A., Ida Muryany, M.Y., Fatimah, H., Nor Fadilah, R., Zalilawati, M.R., Khamsa, S., et al. Anti-amoebic properties of a Malaysian marine sponge Aaptos sp. on Acanthamoeba castellanii. World J Microbiol Biotechnol 28:3 (2012), 1237-1244.
19. [19] Narasimhan, S., Madhavan, H.N., Therese, K.L., Development and application of an in vitro susceptibility test for Acanthamoeba species isolated from keratitis to polyhexamethylene biguanide and chlorhexidine. Cornea 21:2 (2002), 203-205.
20. [21] Zhu, Y.P., Chinese materia medica: chemistry, pharmacology and applications. 1998, CRC Press.
21. [22] Velpandian, T., (eds.) Pharmacology of ocular therapeutics, 2016, Springer.
22. [23] Mazur, T., Hadaś, E., Iwanicka, I., The duration of the cyst stage and the viability and virulence of Acanthamoeba isolates. Trop Med Parasitol 46:2 (1995), 106-108.
23. [24] Turner, N.A., Russell, A.D., Furr, J.R., Lloyd, D., Emergence of resistance to biocides during differentiation of Acanthamoeba castellanii. J Antimicrob Chemother 46:1 (2000), 27-34.
24. [25] Lorenzo-Morales, J., Kliescikova, J., Martinez-Carretero, E., De Pablos, L.M., Profotova, B., Nohynkova, E., et al. Glycogen phosphorylase in Acanthamoeba spp.: determining the role of the enzyme during the encystment process using RNA interference. Eukaryot Cell 7 (2008), 509-517.
25. [26] Liu, G.S., Chan, E.C., Higuchi, M., Dusting, G.J., Jiang, F., Redox mechanisms in regulation of adipocyte differentiation: beyond a general stress response. Cells 1 (2012), 976-993.
26. [27] Khunkitti, W., Lloyd, D., Furr, J.R., Russell, A.D., Acanthamoeba castellanii: growth, encystment, excystment and biocide susceptibility. J Infect 36 (1998), 43-48.
27. [28] Hulme, A.C., The isolation of chlorogenic acid from the apple fruit. Biochem J 53 (1953), 337-340.
28. [29] Huo, X.F., Tang, Y.P., Zhang, Q.L., Luo, S.H., Effect of chlorogenic acid on the macrophages induced by lipopolysaccharide. Acta Acad Med Zunyi 26 (2003), 507-508.
29. [30] Shan, J., Fu, J., Zhao, Z., Kong, X., Huang, H., Luo, L., et al. Chlorogenic acid inhibits lipopolysaccharide-induced cyclooxygenase-2 expression in RAW264. 7 cells through suppressing NF-κB and JNK/AP-1 activation. Int Immunopharmacol 9:9 (2009), 1042-1048.
30. [31] Sato, Y., Itagaki, S., Kurokawa, T., Ogura, J., Kobayashi, M., Hirano, T., et al. In vitro and in vivo antioxidant properties of chlorogenic acid and caffeic acid. Int J Pharm 403:1 (2011), 136-138.
31. [32] Wiart, C., Medicinal plants of the Asia-Pacific: drugs for the future?. 2006, World Scientific Publishing Co Pte Ltd, 603-605.
32. [33] Aqeel, Y., Iqbal, J., Siddiqui, R., Gilani, A.H., Khan, N.A., Anti-acanthamoebic properties of resveratrol and demethoxycurcumin. Exp Parasitol 132:4 (2012), 519-523.
33. [34] Kim, S.S., Lee, C.K., Kang, S.S., Jung, H.A., Choi, J.S., Chlorogenic acid, an antioxidant principle from the aerial parts of Artemisia iwayomogi that acts on 1,1-diphenyl-2-picrylhydrazyl radical. Arch Pharm Res 20 (1997), 148-154.